Document is current
Any future updates will be listed below
-
Authors
Nguyen, Thuy Le Lam
Van Nguyen, Dung
Jin, Yujin
Kim, Lila
Heo, Kyung-Sun https://orcid.org/0000-0003-3800-7665
-
Funding
Funding for this research was provided by:
National Research Foundation of Korea (KNRF-2022R1A2C40017761331482092640103)
- License Information
-
More Information
Article History
Received: 7 July 2024
Accepted: 15 October 2024
First Online: 27 October 2024
Declarations
:
: Lila Kim is a chief executive officer of NeuraGene. KS Heo is an Associate Editor of the Archives of Pharmacal Research, but this status has no bearing on editorial consideration. The other authors have no conflict of interest.
